Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction

Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction

Hamdy MA Ahmed,1–3 Samar Abohamad,2 Mohanad Elfishawi,4 Mohamed Tharwat Hegazy,2 Kadambari Vijaykumar1,5 1Internal Medicine Department, Rochester General Hospital, Rochester, NY, USA; 2Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo Univ...

Full description

Bibliographic Details
Main Authors: Ahmed HMA, Abohamad S, Elfishawi M, Hegazy MT, Vijaykumar K
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Patient Preference and Adherence
Subjects:
Belimumab
subcutaneous
self-injection
patient satisfaction
Online Access:https://www.dovepress.com/subcutaneous-formulation-of-belimumab-in-treatment-of-systemic-lupus-e-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/subcutaneous-formulation-of-belimumab-in-treatment-of-systemic-lupus-e-peer-reviewed-article-PPA

Similar Items